Authors
Loading...
Randomized trial assesses a multilayered architecture for detecting and mitigating frontier AI threats, indicating its broad applicability.
Robert Campbell (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: